NASDAQ: RNXTRenovorx Inc Stock Ownership - Who owns Renovorx?
Insider buying vs selling
Have Renovorx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Voll | Chief Financial Officer | 2026-05-19 | 25,000 | $0.79 | $19.70kBuy |
| Ramtin Agah | Chief Medical Officer | 2026-01-21 | 10,000 | $1.00 | $9.98kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-12-31 | 9,795 | $0.86 | $8.42kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-12-30 | 205 | $0.83 | $169.33Buy |
| Shaun Bagai | Chief Executive Officer | 2025-12-18 | 5,000 | $0.90 | $4.51kBuy |
| Shaun Bagai | Chief Executive Officer | 2025-12-17 | 5,000 | $0.85 | $4.26kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-12-16 | 12,000 | $0.85 | $10.20kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-12-05 | 10,000 | $0.96 | $9.60kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-11-24 | 12,000 | $0.80 | $9.60kBuy |
| Ramtin Agah | Chief Medical Officer | 2025-11-21 | 10,000 | $0.80 | $8.00kBuy |
RNXT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RNXT insiders and whales buy or sell their stock.
RNXT Shareholders
What type of owners hold Renovorx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ramtin Agah | 3.93% | 1,773,460 | $3.12M | Insider |
| Kamran Najmabadi | 2.18% | 985,000 | $1.73M | Insider |
| Of The West Bank | 2.16% | 975,000 | $1.72M | Insider |
| Shaun Bagai | 0.81% | 364,340 | $641.24k | Insider |
| Mark Voll | 0.53% | 239,580 | $421.66k | Insider |
| Una S. Ryan | 0.22% | 97,165 | $171.01k | Insider |
| Laurence Marton | 0.17% | 75,884 | $133.56k | Insider |
| Robert J. Spiegel | 0.09% | 40,983 | $72.13k | Insider |
| K. Angela MacFarlane | 0.09% | 40,983 | $72.13k | Insider |
| Paul Manners | 0.05% | 23,333 | $41.07k | Insider |
RNXT vs Biotech Stocks
Renovorx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.